The evolving therapeutic landscape of Graves’ disease in adults: present and future
The therapeutic landscape of Graves’ hyperthyroidism has been rapidly evolving in the past few years. There has been a shift worldwide toward antithyroid drugs as the preferred first-line therapy with significant interest in thyroid function preservation, even if it requires more than 2 years of ant...
Saved in:
| Main Authors: | Marius N Stan, Chrysoula Dosiou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bioscientifica
2025-07-01
|
| Series: | European Thyroid Journal |
| Subjects: | |
| Online Access: | https://etj.bioscientifica.com/view/journals/etj/14/4/ETJ-25-0078.xml |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Updates in the Management of Graves Disease in
Children
by: Yun Jeong Lee
Published: (2023-12-01) -
Targeted immunotherapies for Graves’ thyroidal & orbital diseases
by: Alan Chun Hong Lee, et al.
Published: (2025-03-01) -
Genetic and Plasma Proteomic Approaches to Identify Therapeutic Targets for Graves’ Disease and Graves’ Ophthalmopathy
by: Ke C, et al.
Published: (2025-02-01) -
Prevalence of Graves ophthalmopathy among patients with thyroid disease
by: Erwin D. Palisoc, MD, et al.
Published: (2010-06-01) -
Prediction of fetal Graves’ disease among pregnant women with Graves’ disease who have undergone thyroidectomy or radioactive iodine therapy: A retrospective observational study
by: Aiko Hosoda, et al.
Published: (2025-07-01)